These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18840469)

  • 41. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
    Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
    Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation of influenza A and B viruses in HeLa cells.
    Yamanaka T; Shirasawa H; Yoshizawa S
    Microbiol Immunol; 1995; 39(5):361-3. PubMed ID: 7565177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Host-cell-dependent role of actin cytoskeleton during the replication of a human strain of influenza A virus.
    Arcangeletti MC; De Conto F; Ferraglia F; Pinardi F; Gatti R; Orlandini G; Covan S; Motta F; Rodighiero I; Dettori G; Chezzi C
    Arch Virol; 2008; 153(7):1209-21. PubMed ID: 18488136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.
    Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A
    J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
    Nishiyama K; Sugawara K; Nouchi T; Kawano N; Soejima K; Abe S; Mizokami H
    Biologicals; 2008 Mar; 36(2):122-33. PubMed ID: 17892946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particle quantification of influenza viruses by high performance liquid chromatography.
    Transfiguracion J; Manceur AP; Petiot E; Thompson CM; Kamen AA
    Vaccine; 2015 Jan; 33(1):78-84. PubMed ID: 25448111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza: propagation, quantification, and storage.
    Szretter KJ; Balish AL; Katz JM
    Curr Protoc Microbiol; 2006 Dec; Chapter 15():Unit 15G.1. PubMed ID: 18770580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avidity of influenza virus: model-based identification of adsorption kinetics from surface plasmon resonance experiments.
    Wang W; Wolff MW; Reichl U; Sundmacher K
    J Chromatogr A; 2014 Jan; 1326():125-9. PubMed ID: 24406143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.
    Genzel Y; Behrendt I; König S; Sann H; Reichl U
    Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrastructural lectinocytochemistry of fowl plague virus-infected and uninfected MDCK cells.
    Cmarková J; Cmarko D; Závodská E; Ellinger A; Pavelka M; Ciampor F
    Acta Virol; 1995 Apr; 39(2):85-93. PubMed ID: 7676941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of a single mutation in neuraminidase on the properties of Influenza B virus isolates.
    Katinger D; Romanova J; Ferko B; Fekete H; Egorov A
    Arch Virol; 2004 Jan; 149(1):173-81. PubMed ID: 14689282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of influenza virus in cell cultures for vaccine preparation.
    Merten OW; Hannoun C; Manuguerra JC; Ventre F; Petres S
    Adv Exp Med Biol; 1996; 397():141-51. PubMed ID: 8718593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.
    Giannecchini S; Clausi V; Nosi D; Azzi A
    Arch Virol; 2009; 154(5):821-32. PubMed ID: 19370391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simple approach to well-defined sugar-coated surfaces for interaction studies.
    Vila-Perelló M; Gutiérrez Gallego R; Andreu D
    Chembiochem; 2005 Oct; 6(10):1831-8. PubMed ID: 16142819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell culture influenza vaccine: an Australian perspective.
    Chang L; Crichton R; Nandapalan P
    Dev Biol Stand; 1999; 98():177-81; discussion 197. PubMed ID: 10494971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.
    Lohr V; Genzel Y; Behrendt I; Scharfenberg K; Reichl U
    Vaccine; 2010 Aug; 28(38):6256-64. PubMed ID: 20638458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.
    Roethl E; Gassner M; Krenn BM; Romanovskaya-Romanko EA; Seper H; Romanova J; Nakowitsch S; Sturlan S; Wolschek M; Sirotkin A; Kiselev O; Muster T; Egorov A
    J Virol; 2011 Nov; 85(21):11139-45. PubMed ID: 21849438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.